DOCM.S (DOCM.S) News
Follow DOCM.S (DOCM.S) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
DocMorris posts Q3 2026 adjusted EBITDA of CHF 600,000
DocMorris reached adjusted EBITDA breakeven ahead of schedule in Q3 2026, posting CHF 600,000. September’s full repurchase of its CHF 49.6 million 2028 convertible bond was financed through a new convertible bond maturin
EARNINGS | Oct 15, 2026, 05:12 AM UTC
H
DocMorris Raises 2026 External Revenue Growth Forecast to 12.5% — 15%
DocMorris raised its 2026 external revenue growth forecast to 12.5%-15% from 9%-13%. Adjusted EBITDA is now forecast above minus CHF 10 million, versus a previous range of minus CHF 17.5 million to minus CHF 10 million.
EARNINGS | Oct 15, 2026, 05:07 AM UTC
H
DocMorris accelerates Rx growth to 78% in Q3; EBITDA breakeven already achieved in Q3 and revenue and EBITDA forecast for 2026 raised again
DocMorris AG / Key word(s): Quarterly / Interim Statement DocMorris accelerates Rx growth to 78% in Q3; EBITDA breakeven already achieved in Q3 and revenue and EBITDA forecast for 2026 raised again 15-Oct-2026 / 07:00 CE
CENTRAL_BANK | Oct 15, 2026, 05:02 AM UTC
L
Swiss stocks — Factors to watch on October 15
ZURICH/GDANSK, Oct 15 (Reuters) — Here are some of the main factors that may affect Swiss stocks on Thursday: Company Statements Docmorris Third-quarter results due. Vat Group Reports highest quarterly order intake and s
EARNINGS | Oct 15, 2026, 04:44 AM UTC